Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–41.

Article  PubMed  Google Scholar 

van Maaren MC, de Munck L, de Bock GH, et al. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. Lancet Oncol. 2016;17(8):1158–70.

Article  PubMed  Google Scholar 

Downs-Canner S, Zabor EC, Wind T, et al. Radiation therapy after breast-conserving surgery in women 70 years of age and older: how wisely do we choose? Ann Surg Oncol. 2019;26(4):969–75.

Article  PubMed  PubMed Central  Google Scholar 

Chu QD, Zhou M, Medeiros KL, Peddi P, Wu XC. Impact of calgb 9343 trial and sociodemographic variation on patterns of adjuvant radiation therapy practice for elderly women (≥70 years) with stage i, estrogen receptor-positive breast cancer: analysis of the national cancer data base. Anticancer Res. 2017;37(10):5585–94.

CAS  PubMed  Google Scholar 

Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–98.

Article  CAS  PubMed  Google Scholar 

Torre-Bouscoulet L, Muñoz-Montaño WR, Martínez-Briseño D, et al. Abnormal pulmonary function tests predict the development of radiation-induced pneumonitis in advanced non-small cell lung Cancer. Respir Res. 2018;19(1):72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bernchou U, Christiansen RL, Asmussen JT, Schytte T, Hansen O, Brink C. Extent and computed tomography appearance of early radiation induced lung injury for non-small cell lung cancer. Radiother Oncol. 2017;123(1):93–8.

Article  PubMed  Google Scholar 

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707–16.

Article  Google Scholar 

Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002;20(20):4141–9.

Article  CAS  PubMed  Google Scholar 

Blamey RW, Bates T, Chetty U, et al. Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British association of surgical oncology (BASO) ii trial. Eur J Cancer. 2013;49(10):2294–302.

Article  CAS  PubMed  Google Scholar 

National Comprehensive Cancer Network. (NCCN) clinical practice guidelines in Oncology. Breast Cancer 2023. Version 1. https://www.nccn.org/professionals/physician_gls/pdf/breastl.pdf.

Chen WR, Deng JP, Wang J, Sun JY, He ZY, Wu SG. Impact of 21-gene recurrence score on chemotherapy decision in invasive ductal carcinoma of breast with nodal micrometastases. Cancer Res Treat. 2019;51(4):1437–48.

Article  PubMed  PubMed Central  Google Scholar 

Sparano JA, Gray RJ, Makower DF, et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med. 2018;379(2):111–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Speers C, Pierce LJ. Postoperative radiotherapy after breast-conserving surgery for early-stage breast cancer: a review. JAMA Oncol. 2016;2(8):1075–82.

Article  PubMed  Google Scholar 

Solin LJ, Gray R, Goldstein LJ, et al. Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the eastern cooperative oncology group E2197 study. Breast Cancer Res Treat. 2012;134(2):683–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang WW, Tong Q, Sun JY, et al. 21-Gene recurrence score assay could not predict benefit of post-mastectomy radiotherapy in t1–2 n1mic er-positive her2-negative breast cancer. Front Oncol. 2019;9:270.

Article  PubMed  PubMed Central  Google Scholar 

Wu SG, Zhang WW, Wang J, et al. 21-Gene recurrence score assay and outcomes of adjuvant radiotherapy in elderly women with early-stage breast cancer after breast-conserving surgery. Front Oncol. 2019;9:1.

Article  PubMed  PubMed Central  Google Scholar 

Chevli N, Haque W, Tran KT, et al. 21-Gene recurrence score predictive for prognostic benefit of radiotherapy in patients age ≥ 70 with T1N0 ER/PR + HER2- breast cancer treated with breast conserving surgery and endocrine therapy. Radiother Oncol. 2022;174:37–43.

Article  CAS  PubMed  Google Scholar 

Sparano JA, Gray RJ, Makower DF, et al. Clinical outcomes in early breast cancer with a high 21-gene recurrence score of 26 to 100 assigned to adjuvant chemotherapy plus endocrine therapy: a secondary analysis of the tailorx randomized clinical trial. JAMA Oncol. 2020;6(3):367–74.

Article  PubMed  Google Scholar 

Kalinsky K, Barlow WE, Gralow JR, et al. 21-gene assay to inform chemotherapy benefit in node-positive breast cancer. N Engl J Med. 2021;385(25):2336–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31(19):2382–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kunkler IH, Williams LJ, Jack WJ, et al. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 2015;16(3):266–73.

Article  PubMed  Google Scholar 

Kunkler IH, Williams LJ, Jack WJL, Cameron DA, Dixon JM. Breast-conserving surgery with or without irradiation in early breast cancer. N Engl J Med. 2023;388(7):585–94.

Article  PubMed  Google Scholar 

Jagsi R, Griffith KA, Harris EE, et al. Omission of radiotherapy after breast-conserving surgery for women with breast cancer with low clinical and genomic risk: 5-year outcomes of idea. J Clin Oncol. 2023;42(4):390–8.

Article  PubMed  Google Scholar 

Zeng Y, Gao W, Chen X, Shen K. Association of 21-gene recurrence score and locoregional recurrence in early breast cancer patients. Cancer Biomark Sect Dis Markers. 2022;35(1):111–8.

Article  CAS  Google Scholar 

Woodward WA, Barlow WE, Jagsi R, et al. Association between 21-gene assay recurrence score and locoregional recurrence rates in patients with node-positive breast cancer. JAMA Oncol. 2020;6(4):505–11.

Article  PubMed  PubMed Central  Google Scholar 

Turashvili G, Chou JF, Brogi E, et al. 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer. Breast Cancer Res Treat. 2017;166(1):69–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanli AN, Tekcan Sanli DE, Aydogan F, et al. Should the breast cancer staging system be revised? Am Surg. 2024;90(5):1066–73.

Article  PubMed  Google Scholar 

Jung J, Suh YJ, Ko BK, et al. Clinical implication of subcategorizing T2 category into T2a and T2b in TNM staging of breast cancer. Cancer Med. 2018;7(11):5514–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zekri J, Al-Foheidi M, Alata M, et al. Adjuvant chemotherapy for patients with breast cancer based on clinical and evolving oncotype dx criteria. Breast Care (Basel). 2020;15(6):642–7.

Article  PubMed  Google Scholar 

Tesch ME, Speers C, Diocee RM, et al. Impact of TAILORx on chemotherapy prescribing and 21-gene recurrence score-guided treatment costs in a population-based cohort of patients with breast cancer. Cancer. 2022;128(4):665–74.

Article  CAS